- Global Pharma News & Resources

Worldwide Pharma Regulatory Management Systems Market Industry to 2027 - Increasing Pharma Business Expansion in Different Regulatory Territories -

DUBLIN--(BUSINESS WIRE)--The "Pharma Regulatory Management Systems Market Research Report by Component, by Deployment, by End User, by Region - Global Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to's offering.

The Global Pharma Regulatory Management Systems Market size was estimated at USD 692.78 million in 2020 and is expected to reach USD 787.00 million in 2021, at a CAGR 14.03% to reach USD 1,737.02 million by 2027.

Competitive Strategic Window: The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix: The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharma Regulatory Management Systems Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis: The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Pharma Regulatory Management Systems Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharma Regulatory Management Systems Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharma Regulatory Management Systems Market?

4. What is the competitive strategic window for opportunities in the Global Pharma Regulatory Management Systems Market?

5. What are the technology trends and regulatory frameworks in the Global Pharma Regulatory Management Systems Market?

6. What is the market share of the leading vendors in the Global Pharma Regulatory Management Systems Market?

7. What modes and strategic moves are considered suitable for entering the Global Pharma Regulatory Management Systems Market?

Market Dynamics


  • Strengthening the regulatory scenario in the pharmaceutical industry
  • Increased focus on reducing manual efforts and errors
  • Demand for streamline the data of medical products and devices


  • High cost of implementation and training at administrative side


  • Innovation in software with improved process to assure effective management of regulatory information
  • Increasing pharma business expansion in different regulatory territories


  • Constantly evolving the regulatory landscape
  • Lower adoption rate in developing countries
  • Cumulative Impact of COVID-19

Companies Mentioned

  • Acolad Group
  • Acuta, LLC
  • Antares Vision
  • ArisGlobal LLC
  • arivis AG By BioMedion AG
  • Computer Sciences Corp
  • Dassault Systemes SE
  • DDi, Inc
  • Dovel Technologies, Inc.
  • Ennov SA
  • Freyr
  • Glemser Technologies Corporation
  • GlobeMed Ltd
  • Health Business Systems Inc.
  • Honeywell International Inc
  • Idhasoft Ltd
  • Informa PLC
  • Instem
  • MasterControl, Inc.
  • MedHOK Inc.
  • NNIT
  • Parexel International
  • pharmaREADY
  • Qualityze Inc
  • Veeva Systems
  • Virtify, Inc.



For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Editor Details

  • Company:
    • Businesswire
Last Updated: 08-Feb-2022